← back to search

Hiroshi Yamagami

Boston Medical Center · JP
Area of research
Epidemiology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Acute Ischemic Stroke Management, Cerebrovascular and Carotid Artery Diseases, Intracerebral and Subarachnoid Hemorrhage Research, and Atrial Fibrillation Management and Outcomes.
h-index
48
citations
8,185
works
456
NIH funding
primary concept
Medicine
email

Recent publications

Tissue factor activity and 1-year mortality in patients with active cancer and acute ischemic stroke: findings from the SCAN study.
2026cited by 1position: contributordoi
Sex differences in the incidence of composite ischemic and bleeding events in ischemic stroke patients with nonvalvular atrial fibrillation and atherosclerosis.
2026cited by 0position: contributordoi
Lipid Management for Secondary Prevention in Atherosclerotic Cardiovascular Disease: A Scoping Review and Scientific Report.
2026cited by 0position: contributordoi
Clinical Effects of Using the Combined Technique in the First Attempt for Acute Large-vessel Occlusion, with Specific Reference to Age Differences.
2026cited by 0position: contributordoi
Fifty-percent diluted contrast medium provides acceptable image quality in cerebral angiography.
2026cited by 0position: contributordoi
Plaque-to-artery signal intensity ratio on time-of-flight magnetic resonance angiography (TOF-MRA) as a predictor of postoperative ischemic lesions after carotid artery stenting.
2026cited by 0position: contributordoi
Atrial cardiomyopathy as a potential embolic source in large vessel occlusion.
2026cited by 0position: contributordoi
Association Between Direct Oral Anticoagulants and the Risk of Internal Carotid Artery Occlusion in Patients Eligible for Thrombectomy.
2026cited by 0position: contributordoi
Outcomes of patients with acute ischemic stroke associated with large vessel occlusion admitted during regular and off-hours: a sub-analysis of the RESCUE-Japan Registry 2.
2026cited by 0position: contributordoi
Outcomes of Witnessed Versus Unwitnessed Patients With Stroke After Endovascular Therapy in the Extended Time Window.
2026cited by 0position: contributordoi
Global challenges in the access of endovascular treatment for acute ischemic stroke (global MT access)
International Journal of Stroke 2025cited by 10position: middledoi
Endovascular Therapy for Patients With Low NIHSS Scores and Large Vessel Occlusion in the 6- to 24-Hour Window
Neurology 2025cited by 7position: middledoi
International practice patterns and perspectives on endovascular therapy for the treatment of cerebral venous thrombosis.
2025cited by 6position: contributordoi
Optimal Antithrombotics for Ischemic Stroke and Concurrent Atrial Fibrillation and Atherosclerosis: A Randomized Clinical Trial.
2025cited by 5position: contributordoi
Recent Advances in Stroke Genetics-Unraveling the Complexity of Cerebral Infarction: A Brief Review.
2025cited by 5position: contributordoi
Global challenges in the access of endovascular treatment for acute ischemic stroke (global MT access).
2025cited by 5position: contributordoi
Endovascular Therapy for Patients With Low NIHSS Scores and Large Vessel Occlusion in the 6- to 24-Hour Window: Analysis of the CLEAR Study.
2025cited by 5position: contributordoi
P2Y<sub>12</sub> Reaction Units With Prasugrel in Acute Large Artery Atherosclerosis and Transient Ischemic Attack: An Open-Label Randomized Controlled Study, ACUTE-PRAS.
2025cited by 4position: contributordoi
<i>RNF213</i>-Related Vasculopathy: An Entity with Diverse Phenotypic Expressions.
2025cited by 3position: contributordoi
Hemorrhagic Complications Following Endovascular Treatment for Atherothrombotic Large Vessel Occlusion.
2025cited by 2position: contributordoi
Impact of Intracranial Hemorrhage After Endovascular Treatment for Medium Vessel Occlusion.
2025cited by 2position: contributordoi
Real-World Patent Foramen Ovale Closure in Japan - Results From 1-Year Follow-up of the Amplatzer<sup>TM</sup> PFO Occluder Japan Post-Marketing Surveillance Study.
2025cited by 1position: contributordoi
Impact of the mode of onset after endovascular treatment for acute ischemic stroke in the post DAWN and DEFUSE-3 era.
2025cited by 1position: contributordoi
You Cannot Manage What You Do Not Measure: Advances in Global Stroke Interventions and the Role of the Mechanical Thrombectomy Access Score.
2025cited by 1position: contributordoi
Cancer-related cerebral embolism caused by metastatic cardiac tumour from renal cell carcinoma.
2025cited by 1position: contributordoi
Antiplatelets before or during endovascular therapy after intravenous thrombolysis for atherothrombotic large vessel occlusion.
2025cited by 1position: contributordoi
Intravenous branched-chain amino acid administration for the acute treatment of hepatic encephalopathy: a systematic review and meta-analysis.
2025cited by 1position: contributordoi
Effect of intravenous alteplase before endovascular therapy for atherothrombotic stroke-related large vessel occlusion: subanalysis of the RESCUE AT-LVO registry.
2025cited by 1position: contributordoi
Endovascular Therapy for Late-Window M2-Segment Middle Cerebral Artery Occlusion: Analysis of the CLEAR Study.
2025cited by 1position: contributordoi
Clinical Outcomes and Factors Associated with Reocclusion after Endovascular Therapy for Intracranial Atherothrombotic Stroke with Large Vessel Occlusion.
2025cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Nobuyuki Sakai · Shizuoka City Shimizu Hospital60 papers (2019–2026) · 39 papers (2019–2025)Masatoshi Koga · Biomedical Research Institute29 papers (2019–2024) · 25 papers (2019–2026)Takeshi Morimoto · Hamamatsu University School of Medicine22 papers (2020–2026) · 22 papers (2020–2026) · 20 papers (2019–2026)Shinichi Yoshimura · Ohkawara Neurosurgical Hospital20 papers (2019–2026)Masafumi Ihara · University College London19 papers (2019–2024)Kazunori Toyoda · Biomedical Research Institute11 papers (2020–2024)Takeshi Yoshimoto · University of Tsukuba11 papers (2020–2025) · 10 papers (2020–2026) · 9 papers (2021–2024)Nobuyuki Ohara · Kobe City Medical Center General Hospital9 papers (2020–2026) · 9 papers (2021–2026) · 8 papers (2020–2024)Daniel Strbian · Bayer (Germany)8 papers (2022–2024)Thanh N. Nguyen · Boston Medical Center8 papers (2021–2025)Manabu Inoue · Panasonic (Japan)8 papers (2020–2024) · 7 papers (2023–2025)